The FDA has announced a recall of 20 lots of FreeStyle and FreeStyle Lite Blood Glucose Test Strips in the United States because they may produce erroneously low blood glucose results when used with FreeStyle or FreeStyle Flash Blood Glucose Meters, and with the OmniPod Insulin Management System. When the test strips are used with FreeStyle Freedom, FreeStyle Lite, and FreeStyle Freedom Lite Meters, test results are not affected. The FreeStyle InsuLinx Meter is not affected by the recall. For lot numbers and other details, see http://www.fda.gov/Safety/Recalls/ucm376975.htm.
The FDA has relaxed the 2010 restrictions on Rosiglitazone-containing diabetes medications, including Avandia, Avandamet, Avandaryl, and generics, because further study has indicated no increased risk of heart attack relative to other diabetes medications. For details see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm376683.htm.
The FDA has announced an update to the earlier Class I recall of all GemStar Infusion Pumps (Models 13000, 13100, 13150, 13086, 13087, 13088) that were either manufactured or had a pressure sensor replaced during servicing of the pump since January 1, 2009, because of pressure sensor calibration drift. For details see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm376723.htm.
The Mid-Atlantic Renal Coalition will sponsor a one-hour online seminar December 17, 2013 on Embracing Patient Engagement. The webinar will cover improving self-efficacy, tailoring, self-tailoring, and evidence-based strategies for improving patient outcomes. Continuing education credits will be provided for nurses, PCTs, social workers, and dietitians. Cost is $25 per facility, including CEUs for multiple staff at each facility. For details and registration information see http://events.r20.constantcontact.com/register/event?oeidk=a07e8a9kcrp6d227a15&llr=bzprggcab.
The Mid-Atlantic Renal Coalition will sponsor a one-hour online seminar December 12, 2013 on the CMS Quality Incentive Program (QIP) that will include information on the measures used in the QIP, and how it relates to CROWNWeb. Continuing education credits will be provided for nurses, PCTs, social workers, and dietitians. Cost is $25 per facility including CEUs for multiple staff at each facility. For details and registration information, see http://events.r20.constantcontact.com/register/event?oeidk=a07e8a94um3294dac9c&llr=bzprggcab.
The National Kidney Foundation has announced the availability of $1000 educational stipends for the 2014 Spring Clinical Meetings April 22-26, 2014 in Las Vegas NV. Applications are now being accepted from nurses and technicians, advanced practitioners, social workers, and dietitians. For details on the stipends see http://www.kidney.org/news/meetings/clinical/general/stipends.cfm. The abstracts deadline is December 2, 2013. See http://www.kidney.org/news/meetings/clinical/index.cfm for details on the conference.
CMS has released the Final Rule for the Calendar Year 2014/Payment Year 2016 Prospective Payment System (PPS) Quality Incentive Program (QIP). The Final Rule can be found at http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ESRDpayment/End-Stage-Renal-Disease-ESRD-Payment-Regulations-and-Notices-Items/CMS-1526-F.html; scroll down on that page to “CMS-1526-F [Display Copy]” for the full text. The web page also includes several Addenda and other details.
The Final Rule document includes details on the PY2014 ESRD PPS base rate, wage index and floor, outlier policy, ICD-10-CM, self- and home-dialysis training adjustment, DME, QIP, applicability, cost analysis, stakeholder comments, outcome trends, rule development and performance scoring methodologies, and a great deal of additional information. The PY2016 QIP includes clinical measures on hgb, adult HD and PD Kt/V, pediatric HD Kt/V, AVF and catheter rates, hypercalcemia, and NHSN HD BSI, and reporting measures on anemia management, mineral metabolism, and ICH-CAHPS.
More comprehensive information can be found at the CMS ESRD Center, http://www.cms.gov/Center/Special-Topic/End-Stage-Renal-Disease-ESRD-Center.html.